Search

Displaying results 8691 - 8700 of 10000 in total
  1. Drug

    Xanthium strumarium var. canadense pollen

    go.drugbank.com/drugs/DB10462
    Approved

    Xanthium strumarium var. canadense pollen is mainly used in allergenic testing.

  2. Drug

    Populus deltoides subsp. monilifera pollen

    go.drugbank.com/drugs/DB10465
    Approved

    Populus deltoides subsp. monilifera pollen is mainly used in allergenic testing.

  3. Drug

    Populus balsamifera subsp. trichocarpa pollen

    go.drugbank.com/drugs/DB10754
    Approved

    Populus balsamifera subsp. trichocarpa pollen is mainly used in allergenic testing.

  4. Drug

    Lolium perenne subsp. multiflorum pollen

    go.drugbank.com/drugs/DB10964
    Approved

    Lolium perenne subsp. multiflorum pollen is mainly used in allergenic testing.

  5. Drug

    Ertumaxomab

    go.drugbank.com/drugs/DB18923
    Investigational

    Ertumaxomab is under investigation in clinical trial NCT00522457 (Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy).

  6. Drug

    Proparacaine

    go.drugbank.com/drugs/DB00807
    ApprovedVet approved

    It is found in ophthalmic solutions at a concentration of 0.5% as the hydrochloride salt.

  7. Drug

    Pregnenolone

    go.drugbank.com/drugs/DB02789
    ApprovedInvestigationalWithdrawn

    A 21-carbon steroid, derived from cholesterol and found in steroid hormone-producing tissues. Pregnenolone is the precursor to gonadal steroid hormones and the adrenal corticosteroids.

  8. Drug

    FavId

    go.drugbank.com/drugs/DB05249
    Investigational

    FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.

  9. Drug

    PDPSC18

    go.drugbank.com/drugs/DB05167
    Experimental

    PDPSC18 is therapeutic DNA vaccine designed to fight chronic infections with the Hepatitis B virus, entering phase I clinical trials.

  10. Drug

    Stannsoporfin

    go.drugbank.com/drugs/DB04912
    Investigational

    Stannsoporfin is a competitive heme oxygenase (HO) inhibitor being developed by InfaCare, a subsidiary of WellSpring Pharmaceuticals, for the prevention of hyperbilirubinemia in infants at risk of developing

    Synonyms: Sn Mesoporphyrin